For a patient with fasting glucose of 210–228 mg/dL who is currently taking insulin glargine (basal insulin) 10 U daily and has received 8 U of short‑acting insulin in the past 24 hours, what is the best way to increase the long‑acting insulin dose?

Increase Glargine by 2 Units Every 3 Days

For a patient with fasting glucose of 210–228 mg/dL on 10 units of glargine daily, increase the basal insulin dose by 2 units every 3 days until fasting glucose reaches target (<100 mg/dL), provided no hypoglycemia occurs. 1

Rationale for This Approach

The 2025 ADA Standards of Care provide explicit guidance for basal insulin titration. The evidence-based algorithm recommends increasing by 2 units every 3 days to reach fasting plasma glucose goals without hypoglycemia 1. This is the standard titration protocol that has been validated in major clinical trials.

Your patient's current situation indicates:

• Inadequate basal coverage: Fasting glucose of 210–228 mg/dL is significantly above target (goal <100 mg/dL)
• Insufficient basal dose: 10 units is a relatively low dose that clearly needs upward titration
• Appropriate short-acting use: The 8 units of short-acting insulin in 24 hours suggests postprandial issues, but the priority is fixing the elevated fasting glucose first by optimizing basal insulin

Specific Titration Protocol

Starting point: Current dose is 10 units glargine daily

Titration schedule:

• Day 1-3: Increase to 12 units
• Day 4-6: Increase to 14 units
• Day 7-9: Increase to 16 units
• Continue this pattern until fasting glucose <100 mg/dL

Alternative approach if more aggressive control is needed: The guidelines also support increasing by 10-15% of the current dose 1. For your patient, this would mean:

• 10% increase = 1 unit every adjustment
• 15% increase = 1.5 units (round to 2 units) every adjustment

The 2-unit increment every 3 days is the preferred evidence-based approach from the Treat-to-Target study 2.

Critical Monitoring Points

Stop or reduce the dose if:

• Blood glucose drops below 72 mg/dL (4.0 mmol/L) 1
• If hypoglycemia occurs without clear cause, reduce dose by 10-20% 1

Check fasting glucose daily during titration to guide adjustments and detect hypoglycemia early.

Common Pitfalls to Avoid

1. Therapeutic inertia: Don't delay increasing the dose. With fasting glucose >200 mg/dL, this patient needs prompt titration 1

2. Overbasalization: Be alert for signs that basal insulin alone won't suffice:

   • Large bedtime-to-morning glucose differential
   • Excessive postprandial glucose excursions
   • Requiring >0.5 units/kg without achieving control 3

3. Ignoring the short-acting insulin pattern: The 8 units of short-acting insulin suggests postprandial hyperglycemia. Once fasting glucose is controlled, if A1C remains above goal, you'll need to formalize prandial insulin dosing (start with 4 units before the largest meal or 10% of basal dose) 1

When to Consider Alternative Strategies

If the patient requires doses exceeding 0.5 units/kg body weight without achieving glycemic targets, research suggests diminishing returns from further basal insulin increases 3. At that point:

• Add GLP-1 receptor agonist if not already prescribed 1
• Formalize basal-bolus regimen with scheduled prandial insulin 1
• Consider fixed-ratio combination products (insulin glargine/lixisenatide) 1

The FDA labeling confirms this approach: titrate based on metabolic needs and glucose monitoring, with adjustments made under medical supervision 4.